News
Important Only
Plains All American Pipeline Reaffirms Guidance
Plains All American Pipeline (NASDAQ:PAA) reported adjusted EBITDA of $672 million for Q2 2025 and reaffirmed its full-year 2025 EBITDA guidance of $2.8 billion to $2.95 billion. The company announced in June 2025 the approximately $3.75 billion sale of its Canadian NGL business to Keyera, an expand...The Motley Fool
Fri, Aug 8
Essent Group Posts $195 Million Profit
Essent Group(NYSE:ESNT) reported second-quarter 2025 results on Aug. 8, 2025, with GAAP net income of $195 million, diluted EPS of $1.93, and annualized return on average equity of 14%. Insurance in force reached $247 billion (up 3% year over year) as of June 30, 2025, and persistency was 85.8%. The...The Motley Fool
Fri, Aug 8
Why Nektar Therapeutics Stock Popped 6% on Friday
Key PointsInvestors were reacting to the biotech's second-quarter earnings report.Revenue was higher than analysts expected, although the net loss was deeper than the consensus.10 stocks we like better than Nektar Therapeutics › Biotech Nektar Therapeutics (NASDAQ: NKTR) unveiled its latest quarterl...The Motley Fool
Fri, Aug 8
Immix Biopharma Inc expected to post a loss of 16 cents a share - Earnings Preview
Immix Biopharma Inc IMMX.OQ IMMX.O is expected to report results on August 11 (estimated) for the period ending September 30 2025LSEG's mean analyst estimate for Immix Biopharma Inc is for a loss of 16 cents per share. The one available analyst rating on the shares is "buy". The mean ...Reuters
Fri, Aug 8
Why SoundHound AI Stock Skyrocketed Today
Key PointsSoundHound AI reported its second-quarter results yesterday and beat Wall Street's sales and earnings targets. The software specialist's sales momentum was very strong in the quarter, and the company raised its full-year sales outlook. SoundHound AI is set to record huge sales growth this ...The Motley Fool
Fri, Aug 8
Spero Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview
Spero Therapeutics Inc SPRO.OQ SPRO.O is expected to show a fall in quarterly revenue when it reports results on August 12 for the period ending June 30 2025LSEG's mean analyst estimate for Spero Therapeutics Inc is for a loss of 38 cents per share. The current average analyst rating on the s...Reuters
Fri, Aug 8
Why Integral Ad Science's Stock Crushed the Market on Friday
Key PointsAll three revenue categories for the company saw year-over-year rises in its latest reported quarter.With that, it wasn't too hard for the company to score beats on both revenue and profitability.10 stocks we like better than Integral Ad Science › The stock of digital advertising analysis ...The Motley Fool
Fri, Aug 8
Lument Finance Trust Inc reports results for the quarter ended June 30 - Earnings Summary
Lument Finance Trust Inc LFT.N reported quarterly adjusted earnings of 5 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 9 cents. The mean expectation of two analysts for the quarter was for earnings of 8 cents per share. Wall...Reuters
Fri, Aug 8
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
X4 Pharmaceuticals Inc XFOR.OQ reported a quarterly adjusted loss of $3.47 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $-2.10. The mean expectation of five analysts for the quarter was for a loss of $4.34 per share. Wall Street ...Reuters
Fri, Aug 8
Greenwich Lifesciences Inc expected to post a loss of 24 cents a share - Earnings Preview
Greenwich Lifesciences Inc GLSI.OQ GLSI.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025LSEG's mean analyst estimate for Greenwich Lifesciences Inc is for a loss of 24 cents per share. The one available an...Reuters
Fri, Aug 8
BioSig Technologies Inc expected to post a loss of 4 cents a share - Earnings Preview
BioSig Technologies Inc BSGM.OQ BSGM.O is expected to show a fall in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025LSEG's mean analyst estimate for BioSig Technologies Inc is for a loss of 4 cents per share. The one available analyst rati...Reuters
Fri, Aug 8
Why Eli Lilly Stock Sank 18% This Week
Key PointsEli Lilly is seeing strong growth from its weight loss drugs. Investors are nervous about tariffs on drugs and weak data from its upcoming pipeline.The stock is cheaper but still trades at a premium valuation. 10 stocks we like better than Eli Lilly › Shares of Eli Lilly (NYSE: LLY) sank 1...The Motley Fool
Fri, Aug 8
TV broadcaster Nexstar in advanced talks to acquire rival Tegna, WSJ reports
Aug 8 (Reuters) - Television broadcaster Nexstar Media Group NXST.O is in advanced talks to acquire rival Tegna TGNA.N, the Wall Street Journal reported on Friday, citing people familiar with the matter. Shares of Tegna surged 30% in extended trading following the report, while Nexstar's shares ...Reuters
Fri, Aug 8
Femasys Revenue Jumps 85 Percent in Q2
Key PointsRevenue surged 84.8% to $0.41 million (GAAP) in Q2 2025, far outpacing consensus estimates (GAAP) but still early-stage in scale.FemBloc gained its first-ever European approval; FemaSeed and FemVue secured new regulatory clearances and partnerships.Net loss (GAAP) narrowed slightly to $4.5...The Motley Fool
Fri, Aug 8
Surrozen Reports Q2 Profit on Gains
Key PointsSurrozen reported GAAP EPS of $2.55 for Q2 2025, exceeding expectations by $3.66 per share (GAAP) due to significant one-time and non-cash gains.Surrozen recorded $1.0 million in research service revenue from a partnership.Operating expenses rose year-over-year, with research and developme...The Motley Fool
Fri, Aug 8
Up 15% in 3 Months, Is Solana a Buy Right Now With $1,000?
Key PointsSolana's price has been trending upward recently.It's gaining ground against Ethereum, continuing the prior trend. It'll need to keep building up its case for institutional adoption to proceed.10 stocks we like better than Solana › Solana's (CRYPTO: SOL) price has climbed by around 15% sin...The Motley Fool
Fri, Aug 8
Biglari Swings to Profit in Fiscal Q2
Key PointsNet earnings (GAAP) swung to a $50.9 million profit in Q2 2025 from a $48.2 million loss a year earlier, driven by $61.4 million in investment gains.Pre-tax operating earnings (non-GAAP) fell 81.4% to $3.7 million.Steak n Shake same-store sales rose 10.7%.These 10 stocks could mint the nex...The Motley Fool
Fri, Aug 8
NET Power Inc expected to post a loss of 11 cents a share - Earnings Preview
NET Power Inc NPWR.N, NPWR.K is expected to report resultson August 11 for the period ending June 30 2025LSEG's mean analyst estimate for NET Power Inc is for a loss of 11 cents per share. The current average analyst rating on the shares is "buy" and the breakdown of recommendations is...Reuters
Fri, Aug 8
C3.ai CEO Tom Siebel Is Stepping Down. Is the Stock in Trouble?
Key PointsThe CEO is resigning for health reasons.C3.ai's stock has struggled since going public in late 2020 and is down over 75%.C3.ai has been growing but also incurring steep losses in recent years.10 stocks we like better than C3.ai › Whenever there's a change in management, it can mark a turni...The Motley Fool
Fri, Aug 8
Entera Bio Beats Q2 EPS Estimates
Key PointsGAAP earnings per share of $0.06 in Q2 2025 beat analyst expectations by $0.17, despite higher research spending.No revenue was reported for the quarter, underscoring Entera Bio's pre-commercial stage and continued reliance on capital reserves.Significant regulatory advances for lead candi...The Motley Fool
Fri, Aug 8
